Want to see HK:0722 full AI Analyst Report?
Top Page
UMP Healthcare Holdings Limited
(0722)
Select Model
Select Model
Rating:51Neutral
Price Target:
HK$0.39
▼(-12.89% Downside)
Action:Reiterated
Date:10/24/26
The score is held back primarily by the sharp 2026 operational deterioration (major revenue decline and losses). Technicals also indicate a downtrend with negative momentum. These are partially offset by a relatively stable balance sheet, still-positive free cash flow, and a high dividend yield, but profitability and trend conditions remain the key constraints.
Positive Factors
Manageable Leverage
Stable, moderate leverage gives UMP Healthcare financial flexibility while it addresses operating challenges. A sizeable equity base and slightly lower debt reduce balance-sheet strain, limit financing pressure, and preserve capacity to support operations or pursue growth.
Negative Factors
Severe Revenue Decline
The exceptional revenue contraction represents a major deterioration in business scale and materially weakens the platform's ability to absorb fixed costs. Sustained recovery in customer activity and service revenue is necessary before prior operating performance can become dependable again.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable Leverage
Stable, moderate leverage gives UMP Healthcare financial flexibility while it addresses operating challenges. A sizeable equity base and slightly lower debt reduce balance-sheet strain, limit financing pressure, and preserve capacity to support operations or pursue growth.
Read all positive factors
UMP Healthcare Holdings Limited (0722) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$292.35M
Dividend Yield9.04%
Average Volume (3M)39.88K
Price to Earnings (P/E)―
Beta (1Y)0.23
Revenue Growth-1.37%
EPS Growth-334.69%
CountryHK
Employees494
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.10
Shares Outstanding810,955,260
10 Day Avg. Volume87,400
30 Day Avg. Volume39,878
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.56
Price to Sales (P/S)0.50
P/FCF Ratio3.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
UMP Healthcare Holdings Limited Business Overview & Revenue Model
Company Description
UMP Healthcare Holdings Limited, an investment firm, delivers a broad spectrum of medical and wellness provisions across Hong Kong, Macau, and mainland China. The company's operations are divided into two main divisions: Corporate Healthcare Solut...
UMP Healthcare Holdings Limited Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
70
Positive
Cash Flow
64
Positive
| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 716.97M | 727.36M | 748.49M | 727.75M | 666.20M |
| Gross Profit | 375.02M | 490.61M | 692.25M | 502.69M | 463.95M |
| EBITDA | 26.97M | 143.30M | 161.98M | 178.21M | 168.03M |
| Net Income | -74.64M | 31.44M | 40.64M | 60.45M | 72.17M |
Balance Sheet | |||||
| Total Assets | 990.71M | 1.10B | 1.11B | 1.12B | 1.04B |
| Cash, Cash Equivalents and Short-Term Investments | 367.89M | 341.70M | 307.49M | 318.58M | 291.65M |
| Total Debt | 143.94M | 161.55M | 172.57M | 172.22M | 148.34M |
| Total Liabilities | 338.39M | 343.53M | 362.14M | 351.54M | 300.30M |
| Stockholders Equity | 640.21M | 742.63M | 725.94M | 740.55M | 698.65M |
Cash Flow | |||||
| Free Cash Flow | 104.73M | 133.76M | 91.54M | 80.71M | 26.40M |
| Operating Cash Flow | 127.02M | 145.40M | 148.78M | 190.04M | 110.91M |
| Investing Cash Flow | -80.85M | 4.13M | -68.49M | -134.09M | -77.12M |
| Financing Cash Flow | -86.01M | -100.00M | -117.13M | -53.67M | -90.98M |
UMP Healthcare Holdings Limited Technical Analysis
Negative
0.45
Price Trends
0.41
Negative
0.43
Negative
0.45
Negative
Market Momentum
-0.01
Positive
20.67
Positive
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0722, the sentiment is Negative. The current price of 0.45 is above the 20-day moving average (MA) of 0.39, above the 50-day MA of 0.41, and above the 200-day MA of 0.45, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 20.67 is Positive, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0722.
UMP Healthcare Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | HK$5.84B | 27.81 | 2.55% | 0.39% | 1.59% | -58.55% | |
52 Neutral | HK$1.10B | 78.10 | 0.48% | 1.10% | -3.26% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$292.35M | -3.79 | -10.76% | 9.04% | -1.37% | -334.69% | |
50 Neutral | HK$467.79M | -143.62 | -0.41% | ― | 3.16% | -101.02% | |
43 Neutral | HK$489.79M | -2.69 | -8.65% | ― | 47.93% | 65.94% |
* Healthcare Sector Average
HK:0722
UMP Healthcare Holdings Limited
0.37
-0.08
-17.61%
HK:2279
Yonghe Medical Group Co., Ltd.
2.10
0.18
9.46%
HK:3869
Hospital Corporation of China Ltd
3.39
-2.61
-43.49%
HK:3886
Town Health International Medical Group Ltd.
0.16
-0.11
-40.07%
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
9.51
-3.57
-27.33%
HK:2453
Concord Healthcare Group Co., Ltd. Class H
0.63
-1.92
-75.39%
UMP Healthcare Holdings Limited Corporate Events
UMP Healthcare Sets AGM to Approve Dividend, Board Slate and Share Buyback Mandate
Oct 22, 2026
UMP Healthcare Holdings Limited has convened its annual general meeting for 20 November 2026 in Hong Kong, where shareholders will review and adopt the audited consolidated financial statements and directors’ and auditor’s reports for ...
UMP Healthcare Swings to Loss as Impairments Hit Earnings and Dividend
Sep 24, 2026
UMP Healthcare Holdings Limited reported a slight 1.4% year-on-year decline in revenue to HK$716.97 million for the year ended 30 June 2026, while total assets fell 9.6% to HK$990.71 million and shareholders’ funds decreased 13.8% to HK$640....
UMP Healthcare Declares Final Dividend for FY2026
Sep 24, 2026
UMP Healthcare Holdings Limited has declared a final ordinary cash dividend of HKD 0.014 per share for the financial year ended 30 June 2026, underscoring its intention to return value to shareholders. The dividend is subject to shareholder approv...
UMP Healthcare Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend
Sep 14, 2026
UMP Healthcare Holdings Limited has scheduled a board meeting for 24 September 2026 to review and approve the consolidated annual results for the financial year ended 30 June 2026. The board will also consider recommending a final dividend and add...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.